Access in-depth articles, white papers and publications discussing strategies for overcoming challenges in the cell and gene therapy industry.
Case Study: The Challenge of Multiple Audits and Redundant Training
Learn about the challenges UCLA Health has encountered with the rapid growth in the cell and gene therapy industry, and how adopting standardized processes can help to overcome these challenges.
White Paper: Risky Business
Learn about the proliferation of quality system audits that threaten to cripple cell collection site capacity and how developing standardized industry processes can create immediate efficiencies for all stakeholders.
Case Study: Cell Collection Standards for Cell Therapies
Learn about our work with the Standards Coordinating Body to standardize common aspects of cell collection protocols and processes and improve cellular starting material quality.
STAT Plus article: A CAR-T bottleneck
Centers that collect patient cells feel crunch from growing demand -- written by Andrew Joseph
Cell & Gene Therapy Insights Interview
Optimizing the Cell Collection Network to Support the Commercialization of Cell and Gene Therapies
White Paper: Exceptions are the Norm
The importance of patient case management to reduce variability in cell therapy supply chains